Brenda Duggan

654 total citations
8 papers, 556 citations indexed

About

Brenda Duggan is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Brenda Duggan has authored 8 papers receiving a total of 556 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Genetics. Recurrent topics in Brenda Duggan's work include Peptidase Inhibition and Analysis (3 papers), Virus-based gene therapy research (2 papers) and Signaling Pathways in Disease (2 papers). Brenda Duggan is often cited by papers focused on Peptidase Inhibition and Analysis (3 papers), Virus-based gene therapy research (2 papers) and Signaling Pathways in Disease (2 papers). Brenda Duggan collaborates with scholars based in Canada and United Kingdom. Brenda Duggan's co-authors include R. Chris Bleackley, Marek Michalak, Eric A. Atkinson, Konrad S. Famulski, Mona Nemer, Kimberly Burns, Corrinne G. Lobe, R. Chris Bleackley, Michael Meier and Jennifer Shaw and has published in prestigious journals such as Nature, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Brenda Duggan

8 papers receiving 541 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brenda Duggan Canada 7 297 232 156 60 58 8 556
Y S Yang United States 7 291 1.0× 130 0.6× 107 0.7× 39 0.7× 29 0.5× 7 433
Karine Missy France 8 352 1.2× 182 0.8× 173 1.1× 39 0.7× 36 0.6× 9 664
Jeroen E.M. van Leeuwen Netherlands 14 467 1.6× 188 0.8× 268 1.7× 40 0.7× 152 2.6× 16 676
Sylvia Papp Canada 12 350 1.2× 166 0.7× 363 2.3× 33 0.6× 64 1.1× 21 683
Paul M. Sincock Australia 11 329 1.1× 112 0.5× 284 1.8× 35 0.6× 88 1.5× 11 772
Karine Landry Canada 9 385 1.3× 182 0.8× 165 1.1× 41 0.7× 27 0.5× 9 575
Dale Powner United Kingdom 12 523 1.8× 169 0.7× 323 2.1× 47 0.8× 70 1.2× 19 779
S Avraham United States 13 370 1.2× 228 1.0× 230 1.5× 35 0.6× 91 1.6× 18 700
U Smola Germany 7 447 1.5× 121 0.5× 72 0.5× 75 1.3× 118 2.0× 9 640
Ling Zhen United States 7 420 1.4× 582 2.5× 125 0.8× 118 2.0× 85 1.5× 8 956

Countries citing papers authored by Brenda Duggan

Since Specialization
Citations

This map shows the geographic impact of Brenda Duggan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brenda Duggan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brenda Duggan more than expected).

Fields of papers citing papers by Brenda Duggan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brenda Duggan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brenda Duggan. The network helps show where Brenda Duggan may publish in the future.

Co-authorship network of co-authors of Brenda Duggan

This figure shows the co-authorship network connecting the top 25 collaborators of Brenda Duggan. A scholar is included among the top collaborators of Brenda Duggan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brenda Duggan. Brenda Duggan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Marcet‐Palacios, Marcelo, Brenda Duggan, Irene Shostak, et al.. (2011). Granzyme B Inhibits Vaccinia Virus Production through Proteolytic Cleavage of Eukaryotic Initiation Factor 4 Gamma 3. PLoS Pathogens. 7(12). e1002447–e1002447. 19 indexed citations
2.
Duggan, Brenda, et al.. (2008). A novel lineage-specific hypersensitive site is essential for position independent granzyme B expression in transgenic mice. Biochemical and Biophysical Research Communications. 368(2). 357–363. 2 indexed citations
3.
Duggan, Brenda, et al.. (1996). Regulation of Murine Granzyme B Gene Transcription in Activated Primary T Cells. Journal of Biological Chemistry. 271(28). 16485–16493. 45 indexed citations
4.
Burns, Kimberly, Brenda Duggan, Eric A. Atkinson, et al.. (1994). Modulation of gene expression by calreticulin binding to the glucocorticoid receptor. Nature. 367(6462). 476–480. 331 indexed citations
5.
Lobe, Corrinne G., Jennifer Shaw, Brenda Duggan, et al.. (1989). Transcriptional regulation of two cytotoxk T lymphocyte-specific serine protease gene. Nucleic Acids Research. 17(14). 5765–5779. 21 indexed citations
6.
Bleackley, R. Chris, Corrinne G. Lobe, Brenda Duggan, et al.. (1988). The Isolation and Characterization of a Family of Serine Protease Genes Expressed in Activated Cytotoxic T Lymphocytes. Immunological Reviews. 103(1). 5–19. 81 indexed citations
7.
Bleackley, R. Chris, et al.. (1988). Isolation of two cDNA sequences which encode cytotoxic cell proteases. FEBS Letters. 234(1). 153–159. 20 indexed citations
8.
Lobe, Corrinne G., Chris Upton, Brenda Duggan, et al.. (1988). Organization of two genes encoding cytotoxic T lymphocyte-specific serine proteases CCPI and CCPII. Biochemistry. 27(18). 6941–6946. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026